Hongchan Huang
Papers
1
Total Citations
9
H-Index
1
About
Hongchan Huang is a leading researcher in non-invasive cancer diagnostics, with a primary focus on liquid biopsy technologies for early lung cancer detection. Her most cited work introduces a groundbreaking, cost-effective pfeRNA-based test that can differentiate benign, suspicious, and malignant pulmonary nodules from blood samples. This non-invasive approach addresses a critical clinical challenge—reducing unnecessary invasive procedures while enabling earlier, more definitive intervention for patients with early-stage lung cancers. With 9 citations on this pivotal 2021 study, Huang’s contributions are shaping the future of precision oncology by translating small non-coding RNA biology into practical diagnostic tools. Her research bridges molecular biology and clinical application, offering a scalable solution for improving lung cancer screening outcomes. Huang’s work is particularly notable for its potential to reduce healthcare costs and patient morbidity, marking her as an emerging innovator in the field of cancer biomarker discovery.
Research Focus
Key Achievements
Top Papers
- 1